Table 1 Patient and treatment characteristics.
Variable | Number of patients (%) |
|---|---|
Age(years) | |
< 60 | 130(47.4) |
≥ 60 | 144(52.6) |
Sex | |
Male | 266(97.1) |
Female | 8(2.9) |
BMI | Median 20.2(range, 13.8 ~ 31.6) |
ECOG performance status | |
ECOG 0 | 177(64.6) |
ECOG 1 | 96(35) |
ECOG 2 | 1(0.4) |
Tumor location | |
Cervical | 13(4.7) |
Upper-thoracic | 55(20.1) |
Mid-thoracic | 126(46) |
Lower-thoracic | 80(29.2) |
Pathology type | |
squamous cell carcinoma | 263(96) |
non-squamous cell carcinoma | 11(4) |
The length of the lesion(cm) | Median 5.6(range, 0.6 ~ 14) |
Clinical stages | |
III | 121(44.2) |
IVA | 95(34.7) |
IVB | 58(21.2) |
N position | |
Mediastinal | 216(78.8) |
Supraclavicular | 100(36.5) |
Celiac | 114(41.6) |
Altitude (meters) | Median 1750(IQR:1420 ~ 1891) |
Radiotherapy dose | |
High dose (> 54 Gy) | 152(55.5) |
Standard dose (≤ 54 Gy) | 122(44.5) |
SIB | |
Yes | 108(39.4) |
No | 166(60.6) |
Chemotherapy | |
Yes | 263(96) |
No | 11(4) |
Concurrent chemotherapy | |
Yes | 167(60.9) |
No | 107(39.1) |
Antiangiogenic targeted therapy | |
Yes | 15(5.5) |
No | 259(94.5) |
Adjuvant therapy | |
Yes | 130(47.4) |
No | 144(52.6) |
